Dose-response characteristics of methylphenidate on locomotor behavior and on sensory evoked potentials recorded from the VTA, NAc, and PFC in freely behaving rats
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Background: Methylphenidate (MPD) is a psychostimulant commonly prescribed for attention deficit/hyperactivity disorder. The mode of action of the brain circuitry responsible for initiating the animals' behavior in response to psychostimulants is not well understood. There is some evidence that psychostimulants activate the ventral tegmental area (VTA), nucleus accumbens (NAc), and prefrontal cortex (PFC). Methods: The present study was designed to investigate the acute dose-response of MPD (0.6, 2.5, and 10.0 mg/kg) on locomotor behavior and sensory evoked potentials recorded from the VTA, NAc, and PFC in freely behaving rats previously implanted with permanent electrodes. For locomotor behavior, adult male Wistar-Kyoto (WKY; n = 39) rats were given saline on experimental day 1 and either saline or an acute injection of MPD (0.6, 2.5, or 10.0 mg/kg, i.p.) on experimental day 2. Locomotor activity was recorded for 2-h post injection on both days using an automated, computerized activity monitoring system. Electrophysiological recordings were also performed in the adult male WKY rats (n = 10). Five to seven days after the rats had recovered from the implantation of electrodes, each rat was placed in a sound-insulated, electrophysiological test chamber where its sensory evoked field potentials were recorded before and after saline and 0.6, 2.5, and 10.0 mg/kg MPD injection. Time interval between injections was 90 min. Results: Results showed an increase in locomotion with dose-response characteristics, while a dose-response decrease in amplitude of the components of sensory evoked field responses of the VTA, NAc, and PFC neurons. For example, the P3 component of the sensory evoked field response of the VTA decreased by 19.8% ± 7.4% from baseline after treatment of 0.6 mg/kg MPD, 37.8% ± 5.9% after 2.5 mg/kg MPD, and 56.5% ± 3.9% after 10 mg/kg MPD. Greater attenuation from baseline was observed in the NAc and PFC. Differences in the intensity of MPD-induced attenuation were also found among these brain areas. Conclusion: These results suggest that an acute treatment of MPD produces electrophysiologically detectable alterations at the neuronal level, as well as observable, behavioral responses. The present study is the first to investigate the acute dose-response effects of MPD on behavior in terms of locomotor activity and in the brain involving the sensory inputs of VTA, NAc, and PFC neurons in intact, non-anesthetized, freely behaving rats previously implanted with permanent electrodes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Picton, T. W., Bentin, S., Berg, P., Donchin, E., Hillyard, S. A., Johnson, R., Miller, G. A., Ritter, W., Ruchkin, D. S., Rugg, M. D., et al. (2000) · Psychophysiology · doi:10.1111/1469-8986.3720127 · Cited by 2,157 · cited 3×
“For examples, P2 reflects feature detection and is observed at the central and frontal areas of the brain [47]; N2 reflects target identification when it is observed at anterior locations of the brain [48]; and P3 reflects further processing and evaluation of the relevant stimulus [49] and updating working memory and…”
InfluentialCellular and molecular mechanisms of drug dependence
Koob, G. F., & Bloom, F. E. (1988) · Science · doi:10.1126/science.2903550 · Cited by 2,070
Diagnosis and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
Goldman, L. S. (1998) · JAMA · doi:10.1001/jama.279.14.1100 · Cited by 1,082
Word recognition in the human inferior temporal lobe
Nobre, A. C., Allison, T., & McCarthy, G. (1994) · Nature · doi:10.1038/372260a0 · Cited by 789 · cited 1×
“However, sensory evoked potential recording is an approach frequently used for analyzing information processing in the human brain [45] because these components reflect cognitive processes at specific, neuroanatomical locations [29,46].”
Kuczenski, R., & Segal, D. S. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68052032.x · Cited by 623 · cited 1×
“The drug has been shown to block the dopamine transporter (DAT) and thereby elevates extracellular dopamine (DA) levels in the ventral tegmental area (VTA), nucleus accumbens (NAc), and prefrontal cortex (PFC), which are brain areas of the mesocorticolimbic DA system involved in the locomotor and reinforcing effects o…”
JENSEN, P. S., HINSHAW, S. P., SWANSON, J. M., GREENHILL, L. L., CONNERS, C. K., ARNOLD, L. E., ABIKOFF, H. B., ELLIOTT, G., HECHTMAN, L., HOZA, B., et al. (2001) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/00004703-200102000-00008 · Cited by 591
Volkow, N. D. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950180042006 · Cited by 575 · cited 1×
“Despite the escalating consumption of MPD [15,16] and the fact that MPD has many of the same neuropharmacological effects as amphetamine and cocaine [14,17], the adverse effects of MPD treatment in children and adults remain controversial.”
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.11.1652 · Cited by 528
Pharmacotherapy of Attention-deficit/Hyperactivity Disorder Reduces Risk for Substance Use Disorder
Biederman, J., Wilens, T., Mick, E., Spencer, T., & Faraone, S. V. (1999) · Pediatrics · doi:10.1542/peds.104.2.e20 · Cited by 493
Arnsten, A. F., & Dudley, A. G. (2005) · Behavioral and Brain Functions · doi:10.1186/1744-9081-1-2 · Cited by 363
Kuczenski, R., & Segal, D. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-16-07264.2002 · Cited by 316 · cited 8×
“0 mg/kg, which fall within the clinical range in treating children and adult with ADHD [50,52,60,61,67,68].”
InfluentialBrandon, C. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00281-0 · Cited by 259
Adolescent exposure to methylphenidate alters the activity of rat midbrain dopamine neurons
Brandon, C. L., Marinelli, M., & White, F. J. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00787-x · Cited by 107 · cited 7×
“Most of the electrophysiological experiments investigating the property of MPD have been conducted in the presence of anesthesia [4,31,32], which is known to modulate CNS activity [33], or used brain slices [34-38] to record the effect of the drug on spontaneous activity and the role of different neurotransmitters in…”
InfluentialDo High Doses of Stimulants Impair Flexible Thinking in Attention-Deficit Hyperactivity Disorder?
DOUGLAS, V. I., BARR, R. G., DESILETS, J., & SHERMAN, E. (1995) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199507000-00011 · Cited by 103
Santosh, P. J., & Taylor, E. (2000) · European Child & Adolescent Psychiatry · doi:10.1007/s007870070017 · Cited by 94
Psychostimulants induce low-frequency oscillations in the firing activity of dopamine neurons
Shi, W.-X., Pun, C.-L., & Zhou, Y. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300534 · Cited by 66 · cited 1×
“Thus, increased extracellular DA level produces inhibition of the firing of DA neurons [54-57] and may result in further attenuation from baseline of P2, N2, and P3 components of VTA, NAc, and PFC neurons as the MPD dosage increased in the present study.”
Perseveration induced by methylphenidate in children: preliminary findings
Dyme, I. Z., Sahakian, B. J., Golinko, B. E., & Rabe, E. F. (1982) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(82)80177-2 · Cited by 56 · cited 1×
“Currently, there is not any empirical data to consistently show linear improvements with dose [25,26] and the adverse effects of high dose levels of MPD [ 27-29 ].”
Cited by
Lange, M., Norton, W., Coolen, M., Chaminade, M., Merker, S., Proft, F., Schmitt, A., Vernier, P., Lesch, K.-P., & Bally-Cuif, L. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.29 · Cited by 175
Zhang, C.-L., Feng, Z.-J., Liu, Y., Ji, X.-H., Peng, J.-Y., Zhang, X.-H., Zhen, X.-C., & Li, B.-M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051910 · Cited by 41
“[21,22], which is associated with a robust DA release in the PFC, caudate-putamen, and nucleus accumbens, etc [1,14,23].”
Jones, Z., & Dafny, N. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-013-1101-2 · Cited by 37
Self-citation
Metadata
- Authors
- Yang, P. B., Swann, A. C., & Dafny, N.
- Venue
- Behavioral and Brain Functions
- Published
- 2006-01-17
- Volume
- 2
- Issue
- 1
- Pages
- 3-3
- ISSN
- 1744-9081 (ISSN-L)
- OpenAlex
- W2151158926
- Cited by
- 51
- References
- 17
- FWCI
- 0.58
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.